Is Abcellera Biologics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ABCL) stock is to Strong Buy ABCL stock.
Out of 1 analyst, 1 (100%) are recommending ABCL as a Strong Buy, 0 (0%) are recommending ABCL as a Buy, 0 (0%) are recommending ABCL as a Hold, 0 (0%) are recommending ABCL as a Sell, and 0 (0%) are recommending ABCL as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year ABCL price target, the average ABCL price target is $5.00, with the highest ABCL stock price forecast at $5.00 and the lowest ABCL stock price forecast at $5.00.
The Wall Street analyst predicted that Abcellera Biologics's share price could reach $5.00 by Jul 11, 2025. The average Abcellera Biologics stock price prediction forecasts a potential upside of 73.01% from the current ABCL share price of $2.89.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.